Related Experiment Video
Updated: Jun 29, 2026
Robotic Taj Mahal Hepatectomy for Hilar Cholangiocarcinoma
Published on: July 14, 2022
[Surgical treatment of 402 consecutive cases for hilar cholangiocarcinoma: Chinese single center experience]
Ning-xin Zhou1, Zhi-qiang Huang, Wen-zhi Zhang
1Institutes of Hepatobiliary Surgery of Chinese People's Liberation Army, General Hospital of Chinese People's Liberation Army, Beijing 100853, China. zhounx301@163.com
Insights
Hilar cholangiocarcinoma (HCCA) resection offers the best prognosis, especially for Type V originating from intrahepatic large bile ducts. Lymph node metastasis significantly impacts long-term survival in HCCA patients.
Area of Science:
- Hepatobiliary surgery
- Surgical oncology
- Gastroenterology
Context:
- Hilar cholangiocarcinoma (HCCA) presents complex surgical challenges.
- Understanding clinical and pathological characteristics is crucial for treatment planning.
- Bismuth-Corlette typing aids in classifying HCCA based on tumor location.
Purpose:
- To analyze clinical typing, pathological features, and surgical strategies for hilar cholangiocarcinoma (HCCA).
- To evaluate the impact of surgical interventions on HCCA outcomes and long-term survival.
- To identify factors influencing surgical success and patient prognosis in HCCA.
Summary:
- Retrospective analysis of 402 HCCA patients revealed varying resection rates based on Bismuth-Corlette type.
- Curative resection showed significantly better survival rates (1-year: 80.3%, 3-year: 41.9%, 5-year: 33.3%) compared to palliative resection.
- Absence of lymph node metastasis was a key factor for improved survival.
Impact:
- Resection remains the primary treatment for HCCA, with curative resection yielding the best outcomes.
- Extended radical resection, including liver lobes, vasculature, and lymph nodes, can prolong survival.
- HCCA Type V, originating from intrahepatic large bile ducts, demonstrates a higher resection rate and better prognosis.
Objective:
To analyze clinical typing, pathologic characteristics of hilar cholangiocarcinoma (HCCA) and surgical strategies and their effects on HCCA, and to explore the factors that influence the surgical outcomes and long-term survival.
Methods:
The data of the 402 patients with HCCA admitted between January 1993 and December 2004 was investigated retrospectively. Primary outcomes examined included clinical typing, pathologic characteristics, surgical procedures and follow-up results. On the basis of Bismuth-Corlette typing, we defined the tumor originated from intrahepatic large bile duct (LBD) as type V (type Va and Vb).
Results:
Among the 402 patients with HCCA, 198 cases accepted curative resection, 102 (51.5%) for radical resection and 96 (48.5%) for palliative resection. Of the rest patients, 8 received orthotopic liver transplantation (OLT), 161 received simple drainage and 35 were not operated on. The resection rates for type I, II, IIIa, IIIb, IV, Va and Vb were 69.4%, 55.5%, 57.4%, 71.7%, 19.6%, 100% and 34.6%, respectively. The one-year survival rates for radical resection, palliative resection, simple drainage and untreated were 80.3%, 53.2%, 26.7% and 9.8%, respectively. And the three-year and five-year survival rates in the four groups were 41.9% and 33.3%, 19.6% and 14.7%, 3.3% and 0, 0 and 0, respectively. Significant difference was found in survival rates between the radical and palliative resection. In the patients who received tumor resection, the ones without lymph nodes metastasis (LNM) survived much longer than those with LNM (P < 0.05). Complications were found in 36.1% of the patients and the mortality rate was 0.3%.
Conclusions:
HCCA type V originated from intrahepatic LBD has higher resection rate and better prognosis. The tumor differentiation is significantly correlated with the prognosis after operation. With HCCA, resection is still the major treatment selection. Curative resection carries the best effect. Extended radical resection of liver lobes, blood vessels, lymph nodes can prolong survive. The problem of high recurrence rate after OLT for HCCA has not been solved yet.
More Related Videos
04:50Complete Laparoscopic Radical Resection of Perihilar Cholangiocarcinoma Type IIIb
Published on: January 17, 2025
05:22Intraoperative Strategy under Complex Vascular Adhesion for Laparoscopic Radical Resection of Bismuth-Corlette Type IIIb Perihilar Cholangiocarcinoma
Published on: February 13, 2026